Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H23ClN2O8 |
Molecular Weight | 478.88 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(C(Cl)=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C
InChI
InChIKey=CYDMQBQPVICBEU-XRNKAMNCSA-N
InChI=1S/C22H23ClN2O8/c1-21(32)7-6-8-15(25(2)3)17(28)13(20(24)31)19(30)22(8,33)18(29)11(7)16(27)12-10(26)5-4-9(23)14(12)21/h4-5,7-8,15,26,28-29,32-33H,6H2,1-3H3,(H2,24,31)/t7-,8-,15-,21-,22-/m0/s1
DescriptionCurator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/17638695 | https://www.ncbi.nlm.nih.gov/pubmed/6404649
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/17638695 | https://www.ncbi.nlm.nih.gov/pubmed/6404649
Chlortetracycline (trade name Aureomycin, Lederle) is a tetracycline antibiotic, the first tetracycline to be identified. It was discovered in 1945 by Benjamin Minge Duggar working at Lederle Laboratories under the supervision of Yellapragada Subbarow. Duggar identified the antibiotic as the product of an actinomycete he cultured from a soil sample collected from Sanborn Field at the University of Missouri. The organism was named Streptomyces aureofaciens and the isolated drug, Aureomycin, because of their golden color. Chlortetracycline inhibits cell growth by inhibiting translation. It binds to the 16S part of the 30S ribosomal subunit and prevents the amino-acyl tRNA from binding to the A site of the ribosome. In veterinary medicine, chlortetracycline is commonly used to treat conjunctivitis in cats.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0006412 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6404649 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | Aureomycin Approved UseUnknown |
|||
Curative | Aureomycin Approved UseUnknown |
|||
Curative | Aureomycin Approved UseUnknown |
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
1560.8 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/32988509/ |
10 mg/kg single, oral dose: 10 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
CHLORTETRACYCLINE plasma | Gallus gallus domesticus population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
13415.51 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/32988509/ |
10 mg/kg single, oral dose: 10 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
CHLORTETRACYCLINE plasma | Gallus gallus domesticus population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
30.59 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/32988509/ |
10 mg/kg single, oral dose: 10 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
CHLORTETRACYCLINE plasma | Gallus gallus domesticus population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
Funbound
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
50% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/32988509/ |
10 mg/kg single, oral dose: 10 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
CHLORTETRACYCLINE plasma | Gallus gallus domesticus population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/pro/aureomycin.html
Cattle: 0.1-10 mg per lb body wt per day; Swine: 10 mg per lb body wt per day; Turkeys: 25 mg per lb body wt per day;
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17638695
Chlortetracycline activity was determined against 37 Mycoplasma putrefaciens isolates. Chlortetracycline was tested at concentrations ranged from 4 to 0.03 mg/ml/ The MIC was defined as the lowest concentration in which there was no bacterial growth, as evidenced by a lack of pH color change at the time the drug-free growth control showed a color change. This change of color was evident after 24 h of incubation.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 520.445
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
WHO-VATC |
QD06AA52
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
WHO-ATC |
A01AB21
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
CFR |
21 CFR 558.140
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
CFR |
21 CFR 558.145
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
CFR |
21 CFR 558.128
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
NCI_THESAURUS |
C1595
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
WHO-ATC |
S01AA02
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
WHO-ATC |
J01AA03
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
CFR |
21 CFR 558.128
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
WHO-VATC |
QA01AB21
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
CFR |
21 CFR 558.145
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
WHO-ATC |
D06AA02
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
WHO-VATC |
QD06AA02
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
WHO-VATC |
QJ51RA01
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
WHO-VATC |
QJ51AA03
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
LIVERTOX |
198
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
EPA PESTICIDE CODE |
6301
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
WHO-VATC |
QJ01AA03
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
CFR |
21 CFR 556.150
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
CFR |
21 CFR 520.441
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
CFR |
21 CFR 520.443
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
WHO-VATC |
QJ51AA53
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
WHO-VATC |
QS01AA02
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
WHO-VATC |
QG51AA08
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
||
|
CFR |
21 CFR 558.140
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHLORTETRACYCLINE
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
PRIMARY | |||
|
C61673
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
PRIMARY | |||
|
57-62-5
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
PRIMARY | |||
|
27644
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
PRIMARY | |||
|
CHEMBL404520
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
PRIMARY | |||
|
DTXSID9022811
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
PRIMARY | |||
|
624
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
PRIMARY | |||
|
DB09093
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
PRIMARY | |||
|
WCK1KIQ23Q
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
PRIMARY | |||
|
m3468
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
PRIMARY | Merck Index | ||
|
2408
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
PRIMARY | RxNorm | ||
|
100000092152
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
PRIMARY | |||
|
200-341-7
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
PRIMARY | |||
|
236
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
PRIMARY | |||
|
D002751
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
PRIMARY | |||
|
SUB06213MIG
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
PRIMARY | |||
|
WCK1KIQ23Q
Created by
admin on Fri Dec 15 15:16:56 GMT 2023 , Edited by admin on Fri Dec 15 15:16:56 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)